Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Schizophrenia
Interventions
DRUG

AQW051

DRUG

Placebo

Trial Locations (7)

10032

Columbia University, New York

21228

Maryland Psychiatric Research Centre, Spring Grove Hospital Grounds, Baltimore

27509

JUH Clinical Research (Duke University),, Butner

60611

Department of Psychiatry & Behavioural Sciences, Feinberg School of Medicine (Northwestern University), Chicago

63110

Washington University, St Louis

90073

West LA VA Healthcare Center (UCLA), Los Angeles

02115

Massachusetts General Hospital (Freedom Trail Clinic), Boston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY